+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
PRAGBOSIMI PRAGBOSIMI

Prag Bosimi Synthetics Share Price

₹1.73 +0.03 (1.76%)
28.51% Fall from 52W High

13 Nov, 2026 4:01 PM (IST)

Prag Bosimi Synthetics live price: ₹1.73. It opened at ₹2 vs previous close ₹2; intraday high/low: ₹2/₹2. The 50 & 200 DMA stand at ₹1.70/₹1.80.

Prag Bosimi Synthetics Performance

  • Today's Low
  • ₹2
  • Today's High
  • ₹2
  • 52 Week Low
  • ₹1
  • 52 Week High
  • ₹2
  • Open Price₹2
  • Previous Close₹2
  • Volume7,330
  • 50 DMA₹1.70
  • 100 DMA₹1.80
  • 200 DMA₹1.80

Prag Bosimi Synthetics Chart

Investment Returns

  • Over 1 Month + 10.19%
  • Over 3 Month -13.5%
  • Over 6 Month -8.47%
  • Over 1 Year -17.62%

Smart Investing Starts Here Start SIP with Prag Bosimi Synthetics for Steady Growth!

Invest Now

Prag Bosimi Synthetics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -1.5
  • PEG Ratio
  • -0.1
  • Market Cap Cr
  • 13
  • P/B Ratio
  • -0.4
  • Average True Range
  • 0.2
  • EPS
  • -1.2
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • 54.28
  • MFI
  • 56.94

Latest Stock News Updates

Prag Bosimi Synthetics Ltd - 500192 - Board Meeting Outcome for Submission Of Un-Audited Financial Results For The Quarter Ended 30Th September, 2026 Along With Limited Review Report Pursuant To Regulation 33(3((D) Of SEBI (LODR) Regulations, 2015

This is to inform you that the Board of Directors of the Company at its Meeting held today i.e. 12th November, 2026 at Mumbai, inter alia has considered and approved the Standalone and Consolidated Un-Audited Financial Results including the Cash Flow Statement for the period ended on 30th September, 2026 and the Statements of Assets and Liabilities as on 30th September, 2026.

Prag Bosimi Synthetics Ltd - 500192 - Submission Of Un-Audited Financial Results For The Quarter Ended 30Th September, 2026 Along With Limited Review Report Pursuant To Regulation 33(3((D) Of SEBI (LODR) Regulations, 2015

Un- Audited Consolidated and Standalone Financials Result for the Quarter ended 30th Sept 2026

Prag Bosimi Synthetics Ltd - 500192 - Board Meeting Intimation for To Consider And Approve Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2026, Along With The Limited Review Report Thereon To Be Issued By The Statutory Auditors Of The Company.

Prag Bosimi Synthetics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve standalone and Consolidated Un-Audited Financial Result for the Quarter and Half year ended on 30th September 2026

Prag Bosimi Synthetics Financials

Prag Bosimi Synthetics Technicals

EMA & SMA

Current Price
₹1.73
+ 0.03 (1.76%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 10
  • 20 Day
  • ₹1.70
  • 50 Day
  • ₹1.70
  • 100 Day
  • ₹1.80
  • 200 Day
  • ₹1.80

Resistance and Support

1.71 Pivot Speed
  • R3 1.90
  • R2 1.80
  • R1 1.80
  • S1 1.70
  • S2 1.60
  • S3 1.50

Prag Bosimi Synthetics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-12 Quarterly Results
2026-08-12 Quarterly Results
2026-05-29 Audited Results
2026-02-13 Quarterly Results
2025-11-12 Quarterly Results

Prag Bosimi Synthetics Shareholding Pattern

51.7%
48.17%
0.13%
0%

Prag Bosimi Synthetics FAQs

Prag Bosimi Synthetics share price is ₹1 As on 15 November, 2026 | 06:04

The Market Cap of Prag Bosimi Synthetics is ₹12.9 Cr As on 15 November, 2026 | 06:04

The P/E ratio of Prag Bosimi Synthetics is -1.5 As on 15 November, 2026 | 06:04

The PB ratio of Prag Bosimi Synthetics is -0.4 As on 15 November, 2026 | 06:04

The 52 week High & Low of Prag Bosimi Synthetics is ₹2.4/₹1.4 respectively As on 15 November, 2026 | 06:04

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23